These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28683198)

  • 81. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates.
    Razumienko E; Dryden L; Scollard D; Reilly RM
    Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications.
    Song HA; Kang CS; Baidoo KE; Milenic DE; Chen Y; Dai A; Brechbiel MW; Chong HS
    Bioconjug Chem; 2011 Jun; 22(6):1128-35. PubMed ID: 21604692
    [TBL] [Abstract][Full Text] [Related]  

  • 83. DTPA complexation of bismuth in human blood serum.
    Montavon G; Le Du A; Champion J; Rabung T; Morgenstern A
    Dalton Trans; 2012 Jul; 41(28):8615-23. PubMed ID: 22678751
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.
    Kang CS; Wu N; Chen Y; Sun X; Bandara N; Liu D; Lewis MR; Rogers BE; Chong HS
    J Inorg Biochem; 2016 Jan; 154():60-6. PubMed ID: 26583705
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.
    D'Huyvetter M; Aerts A; Xavier C; Vaneycken I; Devoogdt N; Gijs M; Impens N; Baatout S; Ponsard B; Muyldermans S; Caveliers V; Lahoutte T
    Contrast Media Mol Imaging; 2012; 7(2):254-64. PubMed ID: 22434639
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
    Good S; Walter MA; Waser B; Wang X; Müller-Brand J; Béhé MP; Reubi JC; Maecke HR
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1868-77. PubMed ID: 18509636
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
    Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
    Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reduction of the hepatic radioactivity levels of [
    Suzuki H; Matsukawa M; Madokoro R; Terasaka Y; Kannaka K; Uehara T
    Nucl Med Biol; 2024; 132-133():108910. PubMed ID: 38636351
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
    J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tumor targeting by an aptamer.
    Hicke BJ; Stephens AW; Gould T; Chang YF; Lynott CK; Heil J; Borkowski S; Hilger CS; Cook G; Warren S; Schmidt PG
    J Nucl Med; 2006 Apr; 47(4):668-78. PubMed ID: 16595502
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry.
    Choudhary N; Dimmling A; Wang X; Southcott L; Radchenko V; Patrick BO; Comba P; Orvig C
    Inorg Chem; 2019 Jul; 58(13):8685-8693. PubMed ID: 31247868
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Monooxorhenium(V) complexes with 222-N
    Demoin DW; Dame AN; Minard WD; Gallazzi F; Seickman GL; Rold TL; Bernskoetter N; Fassbender ME; Hoffman TJ; Deakyne CA; Jurisson SS
    Nucl Med Biol; 2016 Dec; 43(12):802-811. PubMed ID: 27694058
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of three remote radiolabelling methods for long-circulating liposomes.
    van der Geest T; Laverman P; Gerrits D; Franssen GM; Metselaar JM; Storm G; Boerman OC
    J Control Release; 2015 Dec; 220(Pt A):239-244. PubMed ID: 26514291
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
    Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
    [TBL] [Abstract][Full Text] [Related]  

  • 95. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69.
    Persson J; Puuvuori E; Zhang B; Velikyan I; Åberg O; Müller M; Nygren PÅ; Ståhl S; Korsgren O; Eriksson O; Löfblom J
    Sci Rep; 2021 Sep; 11(1):19151. PubMed ID: 34580321
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
    Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging.
    Hoang B; Lee H; Reilly RM; Allen C
    Mol Pharm; 2009; 6(2):581-92. PubMed ID: 19718806
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preclinical characterisation of 111In-DTPA-trastuzumab.
    Lub-de Hooge MN; Kosterink JG; Perik PJ; Nijnuis H; Tran L; Bart J; Suurmeijer AJ; de Jong S; Jager PL; de Vries EG
    Br J Pharmacol; 2004 Sep; 143(1):99-106. PubMed ID: 15289297
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.
    Mitran B; Varasteh Z; Selvaraju RK; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Rosenström U; Orlova A
    Int J Oncol; 2016 May; 48(5):2124-34. PubMed ID: 26983776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.